Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Endocrinologia | EligiMed
Ensayos clinicos
694 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue.
INTERVENTIONAL
Inicio: 1 de dic de 2004
ID: NCT00332488
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
INTERVENTIONAL
Inicio: 1 de sept de 2015
ID: NCT02531035
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral Fasiglifam 25 mg and 50 mg Compared to Placebo When Used in Combination With Sitagliptin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2013
ID: NCT01829464
Completado
Fase 4
ClinicalTrials.gov
Clinical Metabolic and Endocrine Parameters in Response to Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome: A Phase 4 Randomized, Double- Blind and Placebo Control Trial
INTERVENTIONAL
Inicio: 1 de ene de 2003
ID: NCT00679679
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 20 de sept de 2016
ID: NCT02849080
Completado
Fase 4
ClinicalTrials.gov
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
INTERVENTIONAL
Inicio: 1 de mar de 2009
ID: NCT00870194
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects With Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
INTERVENTIONAL
Inicio: 5 de oct de 2018
ID: NCT03690388
Completado
Fase 2
ClinicalTrials.gov
A 12-week, Phase 2 Open-label, Sequential Dose Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 Treatment in Participants With Congenital Adrenal Hyperplasia (TouCAHn)
INTERVENTIONAL
Inicio: 3 de jul de 2023
ID: NCT05907291
Completado
Fase 3
ClinicalTrials.gov
An International Multicentre Randomized Controlled Trial of Intensive Insulin Therapy Targeting Normoglycemia In Acute Myocardial Infarction: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Pilot Study
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00640991
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate the Safety and Efficacy of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
INTERVENTIONAL
Inicio: 17 de sept de 2015
ID: NCT02540993
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
INTERVENTIONAL
Inicio: 1 de jun de 2003
ID: NCT00162240
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk
INTERVENTIONAL
Inicio: 27 de abr de 2018
ID: NCT03496298
Completado
Fase 4
ClinicalTrials.gov
A Randomised, Controlled, Open Label, Multicentre, Multinational, Treat-to-target Trial Investigating the Efficacy and Safety of Intensification With Addition of Bolus Insulin Aspart in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin With or Without Oral Anti-diabetic Drugs: Step-wise Addition Versus Complete Basal-bolus Therapy
INTERVENTIONAL
Inicio: 1 de oct de 2010
ID: NCT01165684
Activo, no recluta
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 1.0 mg/1.0 mg s.c. Once Weekly Versus Tirzepatide 5 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin, SGLT2 Inhibitor or Both
INTERVENTIONAL
Inicio: 5 de nov de 2024
ID: NCT06534411
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3,Single Arm,Open-Label Study Evaluating Ovarian Suppression Following 3 Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination With Endocrine Therapy in Premenopausal Subjects With Hormone-Receptor-Positive (HR+),Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
INTERVENTIONAL
Inicio: 1 de jul de 2021
ID: NCT04906395
Completado
Fase 2
ClinicalTrials.gov
A Phase I/IIa Open-label Investigation of the Safety and Effectiveness of DIABECELL® [Immunoprotected (Alginate-Encapsulated) Porcine Islets for Xenotransplantation] in Patients With Type 1 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01739829
Completado
Fase 3
ClinicalTrials.gov
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
INTERVENTIONAL
Inicio: 16 de oct de 2001
ID: NCT00172133
Terminado
Fase 3
ClinicalTrials.gov
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
INTERVENTIONAL
Inicio: 23 de mar de 2017
ID: NCT03071692
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00356109
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
INTERVENTIONAL
Inicio: 17 de jul de 2017
ID: NCT03214367
Anterior
1
...
31
32
33
...
35
Siguiente
Filtros